Alpha 2.0
Login Register
» Authors » Hajime Yoshifuji

Hajime Yoshifuji

Explore the profile of Hajime Yoshifuji including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 147
Citations 1765
Followers 0
Related Specialties
Rheumatology
Allergy & Immunology
Science
Top 10 Co-Authors
Tsuneyo Mimori
Ran Nakashima
Koichiro Ohmura
Kosaku Murakami
Shuji Akizuki
Masao Tanaka
Koji Kitagori
Akio Morinobu
Motomu Hashimoto
Takao Fujii
Published In
Mod Rheumatol
Rheumatology (Oxford)
Arthritis Res Ther
PLoS One
Mod Rheumatol Case Rep
Affiliations
Soon will be listed here.
Recent Articles
1.
Anti-arthritic effects of polyunsaturated fatty acid rich supplementation combined with selective soluble epoxide hydrolase inhibitors in a collagen-induced arthritis mouse model
Yoshida A, Murakami K, Tsukamoto H, Hotta Y, Nakayama Y, Saito R, et al.
Mod Rheumatol . 2025 Mar; PMID: 40048675
Objectives: Polyunsaturated fatty acids (PUFAs) are healthy fats that contain a double carbon bond. They are made up of omega (ω)-3 and ω-6 PUFAs, where ω-3 PUFAs exhibit beneficial effects,...
2.
Necrotizing Renal Vasculitis Associated with Sarcoidosis in a Patient with Esophageal Cancer: A Case Report
Sasai T, Hiwa R, Kachi S, Shimizu Y, Yamamoto S, Teramoto Y, et al.
Mod Rheumatol Case Rep . 2025 Mar; PMID: 40045600
Sarcoidosis is a multisystem disorder characterized by non-caseating granulomas, often involving the lungs and lymph nodes, but can affect nearly any organ. Renal involvement in sarcoidosis typically presents as hypercalcemia...
3.
The Association of Anti-dsDNA Antibodies with Patient-reported Outcomes of Patients with Systemic Lupus Erythematosus in a Two-consecutive Year Prospective Study
Nakakubo Y, Tsuji H, Takase Y, Yoshida T, Kozuki T, Iwasaki T, et al.
Kobe J Med Sci . 2025 Feb; 70(4):E113-E124. PMID: 39993784
Objectives: To analyse the association of anti-dsDNA Ab with patient-reported outcomes (PROs) in patients with SLE under maintenance treatment, as it has not been clearly understood whether PROs are able...
4.
Memory B cells and their transcriptomic profiles associated with belimumab resistance in systemic lupus erythematosus in the maintenance phase
Iwasaki T, Yoshifuji H, Kitagori K, Sumitomo S, Akizuki S, Nakashima R, et al.
Front Immunol . 2025 Feb; 16:1506298. PMID: 39975549
The factors contributing to the treatment efficacy of belimumab in patients with systemic lupus erythematosus (SLE) in the maintenance phase are unknown. Here, we collected blood samples from patients with...
5.
Performance of the modified 2022 ACR/EULAR giant cell arteritis classification criteria without age restriction for discriminating from Takayasu arteritis
Sugihara T, Harigai M, Uchida H, Yoshifuji H, Maejima Y, Ishizaki J, et al.
Arthritis Res Ther . 2025 Jan; 27(1):19. PMID: 39891304
Objective: To evaluate the ability to discriminate giant cell arteritis (GCA) from Takayasu arteritis (TAK) according to the modified 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology (ACR/EULAR)...
6.
Exploring the Clinical Diversity of Castleman Disease and TAFRO Syndrome: A Japanese Multicenter Study on Lymph Node Distribution Patterns
Otsuka M, Koga T, Sumiyoshi R, Fukui S, Kaneko Y, Shimizu T, et al.
Am J Hematol . 2025 Jan; 100(4):592-605. PMID: 39865257
Individuals diagnosed with Castleman disease (CD) and TAFRO syndrome (characterized by thrombocytopenia, anasarca, fever, bone marrow fibrosis, and organomegaly) displays a wide range of clinical symptoms, including varying patterns of...
7.
Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-onset systemic sclerosis
Tsuji H, Shirakashi M, Hiwa R, Akizuki S, Nakashima R, Onishi A, et al.
Mod Rheumatol . 2025 Jan; PMID: 39821063
[Objective] To investigate differences in autoantibodies, clinical features, and long-term outcomes between juvenile- and adult-onset systemic sclerosis (SSc). [Methods] Autoantibodies and survival rates over a maximum of 20 years were...
8.
Uncommon concurrent pulmonary infections: and in an Anti-MDA5 antibody-positive dermatomyositis patient
Fukumura M, Hiwa R, Yukawa S, Tsuchido Y, Yoshifuji H, Morinobu A
Med Mycol Case Rep . 2025 Jan; 47:100689. PMID: 39760058
A 59-year-old female with anti-MDA5 antibody-positive dermatomyositis was treated with prednisolone, tacrolimus, cyclophosphamide, tofacitinib, and plasma exchange. Five months post-treatment, elevated β-D-glucan levels and a pulmonary shadow on CT were...
9.
Investigator-initiated, multi-center, single-arm, open-label study of the effectiveness of canakinumab in Japanese patients with Schnitzler syndrome
Kambe N, Yamamoto M, Takemura K, Kagami S, Kawahara Y, Yoshifuji H, et al.
Allergol Int . 2024 Dec; PMID: 39690084
Background: Schnitzler syndrome is an adult-onset autoinflammatory disease characterized by an urticaria-like rash and monoclonal gammopathy with fever and fatigue. Although some treatments have shown efficacy in clinical trials, no...
10.
The 2023 revised diagnostic criteria for IgG4-related dacryoadenitis and sialadenitis
Kanda M, Nagahata K, Moriyama M, Takano K, Kamekura R, Yoshifuji H, et al.
Mod Rheumatol . 2024 Oct; PMID: 39441008
Objectives: For the diagnosis of IgG4-related dacryoadenitis and sialadenitis, either revised comprehensive diagnostic criteria or organ-specific diagnostic criteria for IgG4-related dacryoadenitis and sialadenitis in 2008 were applied; however, the collected...